InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Chanda Sanjay. Director active across 1 company, notably AN2 Therapeutics, Inc.. Cumulatively, 6 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €7k. History available since 15 March 2024. The latest transaction was disclosed on 20 February 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Chanda Sanjay is a declarant linked to AN2 Therapeutics, Inc., where the listed role is Chief Development Officer. Across 4 filings in total, the most recent filings we hold cover the period from 2024-03-18 to 2025-02-28, with 0 EUR in purchases and 3862 EUR in sales, and the modal transaction nature is Attribution.